ErbB Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ErbB monoclonal antibodies for advanced research in cell signaling and cancer biology. ErbB monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The ErbB family of receptors, which includes ErbB1 (EGFR), ErbB2 (HER2), ErbB3, and ErbB4, plays a critical role in regulating cell proliferation, differentiation, and survival. Dysregulation of ErbB receptors is often implicated in various cancers, making them significant targets for therapeutic intervention. Understanding the function and signaling pathways of ErbB proteins is essential for developing effective cancer treatments and diagnostic tools. ErbB monoclonal antibodies enable researchers to explore receptor activation, downstream signaling cascades, and protein-protein interactions. Investigating ErbB receptor expression patterns helps identify potential biomarkers for cancer diagnosis and prognosis. ErbB monoclonal antibodies support research in developing targeted cancer therapies and monitoring treatment responses. Santa Cruz Biotechnology monoclonal antibodies for ErbB research continue to support scientists worldwide in advancing our understanding of cancer biology and developing innovative therapeutic strategies.